Spironolactone Tablet
Product Images NDC 67296-2285

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 67296-2285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig (Spironolactone Fig1)

Fig (Spironolactone Fig1)
A Kaplan-Meier survival curve comparing Spironolactone and placebo groups over 48 months. The x-axis represents time in months, and the y-axis shows probability. The graph includes sample sizes (Spironolactone n=822, Placebo n=841) and a log-rank p-value < 0.001, indicating statistical significance between the groups.*
FDA Label Image

Fig (Spironolactone Fig2)

Fig (Spironolactone Fig2)
A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a study comparing spironolactone versus placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACEI use, and beta blocker use. The x-axis ranges from 0.2 to 1.4, indicating relative benefit with spironolactone on the left and placebo on the right.*
FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))
Label for Spironolactone Tablets USP 25 mg, showing 100 tablets. The label indicates it is manufactured by Aurobindo Pharma Limited and marketed by Northstar Rx LLC. It includes storage instructions, dosage advice to see prescribing info, and a container dispensing note. The label also displays an NDC 72603-134-01 and a printing code area.*
FDA Label Image

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))
Label for Spironolactone Tablets, USP 50 mg by NorthStar, containing 100 tablets. The label includes storage instructions, manufacturing details by Aurobindo Pharma Limited, and dispensing information. The label is marked for prescription use only and includes a barcode and lot number area.*
FDA Label Image

Package Label-principal Display Panel (100 mg (100 Tablets Bottle))

Package Label-principal Display Panel (100 mg (100 Tablets Bottle))
The label for Spironolactone Tablets, USP 100 mg, displays a 100-tablet count. It includes storage instructions, manufacturing details for Northstar Rx LLC, and manufacturing by Aurobindo Pharma Limited, India. The label features the NorthStar branding and a barcode on the right side.*
FDA Label Image

Str (Spironolactone Str1)

Str (Spironolactone Str1)
Chemical structure of spironolactone, showing its molecular framework with distinct rings and functional groups including keto and thioester moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.